AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Why Do We Adjust Index Divisor covers the core reasons behind adjustments, including corporate actions and market events, and how they affect benchmarks.
20,620 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
As tech swings create headlines, a $34 ETF offering broad exposure with built in volatility controls rises as a safer...
The bond market is flashing warning signs about the U.S. debt trajectory even as Washington debates spending and Fede...
Three legacy tech giants are pushing new strategies in 2026 as investors weigh durable enterprise moats against consu...
As AI reshapes the job market, a leading tech founder argues Gen Z should pursue two college majors to stay competiti...
Two cloud stock darlings sit at opposite ends of the growth vs profitability spectrum. This guide breaks down gitlab ...
A Georgia-based accessory maker will pay $1.75 million in restitution to Buffalo shooting victims’ families and halt ...
Fresh data from Stanford and ADP shows AI exposure weighing on entry-level hiring, challenging hopes that automation ...
Senate Democrats allege the White House granted tariff exemptions to firms tied to donors, sparking a bipartisan push...
Oruka stock has surged dramatically, propelled by momentum and speculation. A substantial insider sale adds another l...
With earnings approaching, investors wonder if Extra Space Storage stock can deliver reliable income and resilience. ...
As token prices falter, traders are eyeing crypto-linked equities as the potential catalyst for the next crypto recov...